185 related articles for article (PubMed ID: 33814418)
21. The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand Disease.
Seaman CD; Ragni MV
Thromb Haemost; 2020 Aug; 120(8):1159-1165. PubMed ID: 32629500
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.
Federici AB; Baudo F; Caracciolo C; Mancuso G; Mazzucconi MG; Musso R; Schinco PC; Targhetta R; Mannuccio Mannucci P
Haemophilia; 2002 Nov; 8(6):761-7. PubMed ID: 12410644
[TBL] [Abstract][Full Text] [Related]
23. Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.
Topf HG; Strasser ER; Breuer G; Rascher W; Rauh M; Fahlbusch FB
BMC Anesthesiol; 2019 Jan; 19(1):10. PubMed ID: 30630422
[TBL] [Abstract][Full Text] [Related]
24. Treatment of lipedema by low-volume micro-cannular liposuction in tumescent anesthesia: Results in 111 patients.
Wollina U; Heinig B
Dermatol Ther; 2019 Mar; 32(2):e12820. PubMed ID: 30638291
[TBL] [Abstract][Full Text] [Related]
25. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
Peyvandi F; Kouides P; Turecek PL; Dow E; Berntorp E
Blood Rev; 2019 Nov; 38():100572. PubMed ID: 31229334
[TBL] [Abstract][Full Text] [Related]
26. Water-jet-assisted liposuction for the treatment of lipedema: Standardized treatment protocol and results of 63 patients.
Witte T; Dadras M; Heck FC; Heck M; Habermalz B; Welss S; Lehnhardt M; Behr B
J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1637-1644. PubMed ID: 32446570
[TBL] [Abstract][Full Text] [Related]
27. Atherothrombosis in von Willebrand disease: an analysis of the literature and implications for clinical management.
Franchini M; Coppola A
Semin Thromb Hemost; 2012 Mar; 38(2):185-99. PubMed ID: 22422333
[TBL] [Abstract][Full Text] [Related]
28. Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience.
Tran T; Arnall J; Moore DC; Ward L; Palkimas S; Man L
J Thromb Thrombolysis; 2020 Apr; 49(3):431-440. PubMed ID: 31902122
[TBL] [Abstract][Full Text] [Related]
29. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow.
Abshire T
Thromb Res; 2009 Nov; 124 Suppl 1():S15-9. PubMed ID: 19944256
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
31. Summary document on safety and recommendations on liposuction for lipoedema: Joint British association of aesthetic plastic surgeons (BAAPS)/British association of plastic reconstructive and aesthetic surgeons (BAPRAS) expert liposuction group.
Dancey A; Pacifico M; Kanapathy M; MacQuillan A; Ross G; Mosahebi A
J Plast Reconstr Aesthet Surg; 2023 Feb; 77():400-407. PubMed ID: 36638756
[TBL] [Abstract][Full Text] [Related]
32. Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.
Choi S; Brull R
Anesth Analg; 2009 Aug; 109(2):648-60. PubMed ID: 19608843
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
34. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
Federici AB
Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
[TBL] [Abstract][Full Text] [Related]
35. Perioperative management of patients with von Willebrand disease.
O'Donnell JS; Lavin M
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):604-609. PubMed ID: 31808837
[TBL] [Abstract][Full Text] [Related]
36. Perioperative management of von Willebrand disease: a review for the anesthesiologist.
Mazzeffi MA; Stone ME
J Clin Anesth; 2011 Aug; 23(5):418-26. PubMed ID: 21741810
[TBL] [Abstract][Full Text] [Related]
37. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
38. How I manage severe von Willebrand disease.
Leebeek FWG; Atiq F
Br J Haematol; 2019 Nov; 187(4):418-430. PubMed ID: 31498884
[TBL] [Abstract][Full Text] [Related]
39. Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery.
Berger J; Schwartz J; Ramachandran S; Leff JD
J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3446-3457. PubMed ID: 31570241
[No Abstract] [Full Text] [Related]
40. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease.
Franchini M; Mannucci PM
Thromb Haemost; 2014 Sep; 112(3):427-31. PubMed ID: 24898873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
